SBIR-STTR Award

402 - Rfp: N43-Cm-87007-68 Topic 251: Development Of Anticancer Agents Reques
Award last edited on: 2/5/14

Sponsored Program
SBIR
Awarding Agency
NIH : NCI
Total Award Amount
$149,558
Award Phase
1
Solicitation Topic Code
-----

Principal Investigator
Gary Lee Olson

Company Information

Provid Pharmaceuticals Inc

7 Deer Park Drive Suite D
Monmouth Junction, NJ 08852
   (732) 565-1101
   N/A
   www.provid.com
Location: Single
Congr. District: 12
County: Middlesx

Phase I

Contract Number: N43CM0800025
Start Date: 00/00/00    Completed: 00/00/00
Phase I year
2008
Phase I Amount
$149,558
This project aims to further develop 10-aryl deazaflavin compounds that have been shown to be inhibitors of HDM2's ubiquitin ligase.

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
----
Phase II Amount
----